Study Details

Study Objective

The purpose of this study is to see if an investigational [new/not available on the market and not yet approved by the U.S Food and Drug Administration (FDA)] capsule is bioequivalent (where the active test study drug is absorbed into the body at the same rate and amount as an already approved drug) to a currently marketed capsule, as well as to monitor the safety of the study participants.

Study Schedule

General Screening

N/A

Medical Screening

Tue, Apr 05, Wed, Apr 06 and Fri, Apr 09

Study Visit(s)

Group 3 / Period I
Check-in: Thu, Apr 14, 2022
Check-out: Sat, Apr 16, 2022
Ambulatory 1: Sat, Apr 16, 2022
Ambulatory 2: Sun, Apr 17, 2022

Group 3 / Period II
Check-in: Thu, Apr 21, 2022
Check-out: Sat, Apr 23, 2022
Ambulatory 1:Sat, Apr 23, 2022
Ambulatory 2: Sun, Apr 24, 2022

Follow-Up Visit(s)

N/A

Other Notes

General good health and non-smoker

Study requires overnight stays